OI type 3 is the most severe form of osteogenesis imperfecta that is compatible with survival. Sometimes called “brittle bone disease,” it causes extreme bone fragility, progressive skeletal deformities, and significantly short stature. Fractures often occur during the newborn period simply from handling the infant, and a diagnosis is typically made shortly after birth.
The condition is also known as “progressive deforming osteogenesis imperfecta” or “severe osteogenesis imperfecta,” names that reflect how the skeletal problems tend to worsen over time rather than stay stable.
What Causes OI Type 3
OI type 3 results from mutations in either the COL1A1 or COL1A2 gene. These genes carry instructions for building type I collagen, the protein that gives bones their structure and flexibility. In types 2, 3, and 4 of OI, the mutations don’t just reduce the amount of collagen produced. They alter the structure of the collagen itself, creating molecules that are abnormally shaped and weaker than normal.
Most infants born with OI type 3 have no family history of the condition. The mutation is new (sporadic), meaning it occurred spontaneously rather than being passed down from a parent. This is one reason the diagnosis can come as a complete surprise to families.
How It Affects the Skeleton
The hallmark of OI type 3 is severe bone fragility that leads to frequent fractures throughout life, beginning in infancy. Bones fracture from minimal force, and the repeated cycles of breaking and healing cause progressive deformities, particularly bowing of the long bones in the arms and legs. Spinal curvature (scoliosis) is common, and the ribcage can become barrel-shaped or compressed, which creates problems beyond the skeleton itself.
Growth deficiency is a cardinal feature. Children with OI type 3 follow growth curves well below those of the general population, and the typical pubertal growth spurt is generally absent or blunted. Research on longitudinal growth patterns has found that OI type and gender both significantly affect stature, though the specific collagen gene that’s mutated does not seem to make a difference. Most adults with OI type 3 are significantly shorter than average, and many use wheelchairs for mobility.
Symptoms Beyond the Bones
While fractures and deformities are the most visible features, OI type 3 affects several other parts of the body:
- Dental problems: Many people with OI type 3 develop dentinogenesis imperfecta, a condition where the inner layer of the teeth (dentin) forms abnormally. This makes teeth discolored, weak, and prone to breakage and decay. Both baby teeth and adult teeth can be affected.
- Blue or gray sclerae: The whites of the eyes often have a blue or grayish tint because the thinned connective tissue allows underlying blood vessels to show through.
- Hearing loss: This can develop during childhood or adolescence and tends to worsen over time.
- Macrocephaly: An unusually large head relative to the body is a recognizable feature, partly due to the short stature and partly due to changes in skull bone development.
Symptoms vary significantly from person to person, even among individuals with the same type. Some people experience all of these features, while others have only a few.
How It Differs From Other OI Types
OI is classified into several types based on severity. Type 1 is the mildest form, with fewer fractures and near-normal stature. Type 2 is the most severe and is typically fatal in the newborn period or shortly after. Type 3 sits between these extremes: it is the most severe form in which long-term survival is expected, though life expectancy is often somewhat shortened. Type 4 is moderate, with symptoms that overlap the milder end of type 3.
What sets type 3 apart from type 4 is the progressive nature of the bone deformities and the degree of growth impairment. In growth studies, the height curves for types 3 and 4 do overlap, but children with type 4 can reach the lower range of the general population’s height curves, while children with type 3 generally do not.
Medical Treatment
There is no cure for OI type 3, but treatment focuses on strengthening bones, preventing fractures, and managing deformities. Medications that slow bone breakdown are the primary drug approach. These work by reducing the activity of cells that normally dissolve old bone, which allows bone density to gradually increase. In children with OI, these medications are typically given through an IV infusion on a regular schedule.
Physical therapy plays an important role in maintaining mobility and muscle strength. Because bones get stronger when muscles pull on them, carefully designed exercise programs can reduce fracture risk, though they need to be tailored to what each person’s body can tolerate.
Surgical Rodding
For many people with OI type 3, surgery to place metal rods inside the long bones is a key part of treatment. The goal is to straighten bones that have become bowed or deformed and to provide internal support that helps prevent future fractures. The gold standard is a telescopic rod, which consists of two sliding components anchored at each end of the bone. As a child grows, the rod extends rather than needing immediate replacement.
In very young children or those with extremely narrow bone canals, surgeons sometimes use simpler, non-telescopic rods as a temporary measure. These are less invasive to place but don’t grow with the child. A study of non-telescopic titanium elastic nails in OI type 3 patients found a 75% revision rate within five years, with most revisions needed because the rods migrated, broke, or stopped functioning as the child grew. Pain after surgery was typically manageable within the first three days, and 70% of patients reported no pain by five weeks. Most patients treated with a single rod regained 90 degrees of knee and hip movement within five weeks.
Respiratory Risks
One of the more serious complications of OI type 3 comes from the chest wall. When the ribcage is deformed or compressed by scoliosis, the lungs can’t expand fully. This makes respiratory infections more dangerous and increases the risk of pneumonia. Chest wall deformities are a primary driver of the somewhat shortened life expectancy associated with type 3, making respiratory health an important focus of ongoing care.
Daily Life With OI Type 3
Most people with OI type 3 use a wheelchair for mobility, at least part of the time. The combination of short stature, bone fragility, and skeletal deformities makes independent walking difficult or impossible for many, though some individuals do walk short distances with assistive devices. Fracture frequency tends to decrease after puberty, which can bring a noticeable improvement in quality of life during the teenage years and into adulthood.
Adaptations at home, school, and work are essential. This includes accessible transportation, modified physical activities, and awareness among caregivers about safe handling techniques. Many people with OI type 3 live independently and pursue careers, education, and active social lives, though the condition requires ongoing medical management and practical accommodations throughout life.